acromegaly

Image of a neon sign with the word no lit up next to an unlit yes
Manufacturing

FDA stymies Camurus' drug over 3rd-party manufacturing issues

The FDA dealt Camurus a setback to its efforts to bring its treatment for the hormonal disorder acromegaly to market due to manufacturing issues.
Joseph Keenan Oct 22, 2024 9:53am
acromeagly awarness

Crinetics rolls out new acromegaly disease treatment campaign

Aug 9, 2024 9:35am